ClarientInvestor relations platform

Features

Everything you need. Nothing you have to babysit.

Your Investor Centre, the workflow behind it, and the investor information your team needs. Deliberately simple, and built for the way listed companies actually operate.

0106 features

Your Investor Centre

Most small-caps make do with a static page and a contact email. Clarient gives you a living Investor Centre: current, branded, and built to answer.

Clinuvel Pharmaceuticals
ASX: CUV
Follow updates
HighlightsWhy ownQ&A
Photomedicine · Profitable
Treating the unmet need in rare photomedicine.

A profitable, net-cash biopharmaceutical company. Vitiligo Phase III data expected H2 2026.

Ask a questionInvestment case →
ASX: CUV
Healthcare · Pharma
Delayed
14.52A$
+0.26 · +1.82%
Open
14.30
Volume
138.4k
Mkt cap
720m
A$11.8052-weekA$16.40

Branded investor home

A single public home on your Investor Centre where investors follow you, read announcements, ask questions and see approved answers.

Live stock overview

A delayed ASX price with day range, volume and a 52-week range bar, refreshed automatically.

Company highlights

Cash, debt, revenue and milestones in a handful of headline numbers. Each links to the announcement that confirmed it.

Investment case

A clear, company-controlled statement of why investors hold the stock, with key financials beside it.

Catalyst calendar

Upcoming results, milestones and meetings, so investors know what is coming and when.

Source documents

Announcements, reports and presentations in one library, with the original PDFs one click away.

Quarterly Activities & Cashflow Report
ASX announcement · 30 Apr 2026 · 14-page PDF
ANNOUNCEMENT SUMMARY

The company held A$170M in cash at quarter end with operating outflows of A$9.1M. The Vitiligo Phase III trial remains on track, and the report notes no change to previously stated spending priorities.

Open source PDFAsk a question3 related answers
0204 features

Announcements & summaries

Every ASX announcement becomes something investors can actually use, the moment it is released.

Automatic feed

New ASX filings are added to your Investor Centre automatically, within minutes of release.

Announcement summaries

Each filing becomes a short, plain-English summary your team reviews before it goes live.

Ask about a filing

Investors can ask a question straight from any announcement. It goes to your team's inbox.

Original source PDF

The original filing sits one click away, right beside the plain-English summary.

0306 features

Answering questions

The core loop. A question comes in, a draft is prepared from your own disclosures, you approve it, then you choose where it goes. Some answers belong on your Investor Centre; others are better as a direct reply. The audience is your call.

Inbox
Cash runway after the quarterly?
7 investors asked
Webinar replay?
Already answered
Draft

Based on the latest quarterly, the company held $142.4M in cash at period end…

Quarterly report · p.2
Send toInvestor CentreEmail asker

Ask-a-question form

Investors ask from your Investor Centre. Similar published answers appear before they submit a duplicate.

Question inbox

Every question in one place: who asked, how many asked the same thing, and whether it is answered.

Drafts from your filings

Draft answers are prepared from your public documents, with the supporting filing shown beside each line.

Unsupported claims flagged

If the company has not disclosed something, the draft says so. It does not guess.

Management approval

You review, edit and approve every answer before anything leaves the building. No auto-publish.

Publish, email, or both

Each approved answer can go to the investor who asked by email, be published on your Investor Centre, or both. Not every answer needs to be public.

Top holdersPrivate to your team
1Vanguard Investments12.4%+0.6
2L1 Capital8.1%+0.2
3Retail (4,210)21.7%−0.4
4Pendal Group5.3%flat
0406 features

Knowing your investors

When your shareholder register is connected, you see who holds you and who is moving. It stays private to your team, and it never touches a public answer.

Shareholder register view

Connect or upload register data to see top holders, new holders, reducing holders and exits.

Investor list and notes

Each investor's questions, follow status, notes, tags and follow-ups in one place.

Useful segments

Group investors by holding size, activity or your own tags, for outreach that fits.

Engagement analytics

Follower growth, the most-asked topics, and how quickly questions get answered.

Themes from inbound questions

See recurring topics in the questions that reach you the same way they always have—email, phone, LinkedIn, brokers and the contact form—so you know what deserves a clear public answer.

Private by default

Shareholder register information informs your team's work. It never appears in a public answer.

0506 features

Operating rhythm

The supporting cast. Updates, deadlines, alerts and a complete activity record, so investor communication never quietly goes dark.

Upcoming
Appendix 4C, JuneDue 31 Jul
Phase III readoutH2 CY2026
AGM FY26Nov 2026

Company updates

Write or upload an update once. It reaches your Investor Centre and your followers' inboxes together.

Same story, more than one channel

One draft for your Investor Centre, follower email, and social—so you are not rewriting the same update three times.

Calendar

Reporting deadlines, AGMs, planned updates and follow-ups, so communication keeps a rhythm.

Alerts

The dashboard surfaces what needs attention: unanswered questions, new filings, register moves.

Activity history

Drafts, approvals, publishes and sends are recorded automatically: who, what and when.

Team roles

Owners, editors and approvers work together without giving everyone publish access.

The shift

What Clarient replaces.

Scattered PDFs and a contact form
A live Investor Centre with Q&A and follow capture
Re-typing the same answer by hand
One approved answer you can reuse, publish or resend
Opening every filing PDF yourself
Plain-English announcement summaries linked to the source
A spreadsheet of investor contacts
An investor list with history, notes and register data
Calendar reminders and sticky notes
An activity log and an alerts dashboard

The best way to evaluate it is on your own filings.

Give us your ASX ticker and we'll build a walkthrough from your company's actual public documents.

Features — Clarient